Clinical Trials Logo

Clinical Trial Summary

The development of efficacious, safe, and shorter treatment regimens could significantly improve TB management and treatment success rates. This prospective, 3-year, single arm study is to evaluate the efficacy and safety of a short-course, 4-month regimen including isoniazid(H), pyrazinamide(P), rifapentine (P), and moxifloxacin(M) (2HZPM/2HPM) for the treatment of drug-susceptible, pulmonary tuberculosis, and compared with a historical control group receiving the standard six-month regimen.


Clinical Trial Description

Shorter regimens have the potential to impact on TB control by reducing TB incidence and mortality, and improve outcomes by increasing patient adherence to treatments and decreasing duration to cure, in addition to reducing costs to the health system and the patient. The purpose of this prospective, three year, single arm study is to evaluate whether a short course, four-month regimen containing rifapentine and moxifloxacin (2HZPM/2HPM) are as effective and/or as tolerable as the standard six-month regimen for the treatment of drug-susceptible, pulmonary tuberculosis (TB). A historical group receiving the standard six-month regimen is used as control. The pharmacokinetic and pharmacodynamic profile of rifapentine in Asian patients. Analysis of of histocompatibility leucocyte antigen (HLA) associations with adverse events and changes in biomarkers will be done. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04856644
Study type Interventional
Source Kaohsiung Veterans General Hospital.
Contact Susan Shin-Jung Lee, M.D., Ph.D.
Phone +886-7342-2121
Email [email protected]
Status Not yet recruiting
Phase Phase 3
Start date May 1, 2021
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Terminated NCT03028129 - Prevention of Tuberculosis in Prisons Phase 4
Withdrawn NCT03862248 - Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More Phase 3
Completed NCT03271567 - Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
Completed NCT03199313 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid Phase 1
Active, not recruiting NCT03251196 - TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
Not yet recruiting NCT04485156 - Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3) Phase 3
Active, not recruiting NCT02715271 - Study of TB Lesions Obtained in Therapeutical Surgery
Completed NCT01364324 - Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Recruiting NCT03044158 - GeneXpert Performance Evaluation for Linkage to Tuberculosis Care N/A
Completed NCT01130311 - Replacement of Vitamin D in Patients With Active Tuberculosis N/A
Recruiting NCT04122404 - POC Strategies to Improve TB Care in Advanced HIV Disease N/A
Completed NCT04848246 - Effect of Smoking Cessation on Tuberculosis Treatment Outcomes N/A
Recruiting NCT04694586 - Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide Phase 2
Active, not recruiting NCT03086486 - Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary, XDR-TB, Pre- XDR-TB or Non-responsive/Intolerant MDR-TB (ZeNix) Phase 3
Recruiting NCT02972697 - Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB Phase 1
Recruiting NCT02967666 - Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts Phase 1
Completed NCT02153528 - Optimization of the TB Treatment Regimen Cascade Phase 3
Completed NCT01218217 - Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB Phase 2
Completed NCT00004444 - Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis N/A
Active, not recruiting NCT03519425 - A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in Malawi N/A